Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C

Introduction: Impaired activity of natural killer (NK) cells has been proposed as a mechanism contributing to viral persistence in hepatitis C virus (HCV) infection. As the function of NK cells is primarily regulated by NK cell receptors (NKR), we analysed whether decreased NK cell function in hepatitis C may be related to dysregulated NKR expression. Patients and methods: Expression of NK cell was analysed by flow cytometry on lymphocytes from HCV(+) subjects (n = 30), patients who became HCV(−) after antiviral therapy (n = 10), healthy individuals (n = 10), and hepatitis B virus (HBV) infected patients (n = 9). Cytolytic function of lymphocytes was studied in a redirected lysis assay and in a standard 51chromium release cytotoxicity assay, respectively. Results: In patients with chronic hepatitis C, we found a significantly reduced proportion of NKp46 and NKp30 expressing NK cells compared with healthy and HBV infected subjects. Low expression of natural cytotoxicity receptor (NCR) was also confirmed in in vitro activated NK cell populations derived from HCV patients compared with uninfected donors. In contrast, patients who cleared HCV under antiviral therapy showed normal expression of NKp44, NKp30, and NKp46. Reduced NCR expression in chronic hepatitis C was associated with a parallel decrease in NCR mediated target cell killing. Furthermore, we found a significantly increased proportion of NKG2A expressing NK cells and CD8+ T cells in HCV positive patients, resulting in a reduced cytolytic activity against cells incubated with the HLA-E stabilising peptide HCV core35–44. Conclusion: The present study indicates that defective expression of NKR represents a novel mechanism contributing to impaired function of NK cells and CD8+ T cells in chronic hepatitis C.

[1]  G. Ahlenstiel,et al.  The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. , 2005, The American journal of pathology.

[2]  N. Hayashi,et al.  Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.

[3]  F. Alvarez,et al.  Role of NK and NKT cells in the immunopathogenesis of HCV‐induced hepatitis , 2004, Journal of leukocyte biology.

[4]  Salim I. Khakoo,et al.  HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection , 2004, Science.

[5]  L. Moretta,et al.  Unravelling natural killer cell function: triggering and inhibitory human NK receptors , 2004, The EMBO journal.

[6]  L. Moretta,et al.  The impaired NK cell cytolytic function in viremic HIV‐1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44) , 2003, European journal of immunology.

[7]  W. Ferlin,et al.  Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells. , 2003, Trends in immunology.

[8]  C. Sarkar,et al.  Transforming growth factor beta in hepatitis C virus infection: In vivo and in vitro findings , 2003, Journal of gastroenterology and hepatology.

[9]  R. Biassoni,et al.  Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  L. Moretta,et al.  NK-CTLs, a novel HLA-E-restricted T-cell subset. , 2003, Trends in immunology.

[11]  R. Winchester,et al.  TCR specificity dictates CD94/NKG2A expression by human CTL. , 2002, Immunity.

[12]  Anthony M. Byers,et al.  NK cell receptors in antiviral immunity. , 2002, Current opinion in immunology.

[13]  T. Graf,et al.  Making Eosinophils Through Subtle Shifts in Transcription Factor Expression , 2002, The Journal of experimental medicine.

[14]  P. Jensen,et al.  CD94-NKG2A receptors regulate antiviral CD8+ T cell responses , 2002, Nature Immunology.

[15]  S. Nuti,et al.  Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.

[16]  C. Tseng,et al.  Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.

[17]  A. Hughes,et al.  The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.

[18]  D. Raulet,et al.  Expression and function of NK cell receptors in CD8+ T cells. , 2001, Current opinion in immunology.

[19]  L. Lanier,et al.  Face off--the interplay between activating and inhibitory immune receptors. , 2001, Current opinion in immunology.

[20]  A. Diehl,et al.  Emergence of CD8+ T Cells Expressing NK Cell Receptors in Influenza A Virus-Infected Mice1 , 2000, The Journal of Immunology.

[21]  R. Biassoni,et al.  Human NK-cell receptors. , 2000, Immunology today.

[22]  P. Klenerman,et al.  Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. , 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[23]  J. Ellwart,et al.  Cutting Edge: The Human Cytomegalovirus UL40 Gene Product Contains a Ligand for HLA-E and Prevents NK Cell-Mediated Lysis1 , 2000, The Journal of Immunology.

[24]  R. Biassoni,et al.  Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. , 2000, Immunology today.

[25]  R. Biassoni,et al.  Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells , 1999, The Journal of experimental medicine.

[26]  D. Speiser,et al.  In Vivo Expression of Natural Killer Cell Inhibitory Receptors by Human Melanoma–Specific Cytolytic T Lymphocytes , 1999, The Journal of experimental medicine.

[27]  R. Biassoni,et al.  NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells , 1999, European journal of immunology.

[28]  P. A. Peterson,et al.  Cell surface expression of HLA‐E: interaction with human β2‐microglobulin and allelic differences , 1999, European journal of immunology.

[29]  R. Biassoni,et al.  Molecular Cloning of NKp46: A Novel Member of the Immunoglobulin Superfamily Involved in Triggering of Natural Cytotoxicity , 1998, The Journal of experimental medicine.

[30]  A. Kasahara,et al.  Cross‐linking of Fcγ‐receptor on monocytes inhibits hepatitis C virus‐specific cytotoxic T‐lymphocyte induction in vitro , 1998, Immunology.

[31]  L. Moretta,et al.  NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis , 1998, The Journal of experimental medicine.

[32]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[34]  R. Bellomo,et al.  HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Eric Vivier,et al.  Inhibition of antigen‐induced T cell response and antibody‐induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP‐1 and SHP‐2 protein‐tyrosine phosphatases , 1998, European journal of immunology.

[36]  I. Melero,et al.  Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. , 1995, Journal of immunology.

[37]  G. Feldmann,et al.  633 Enhanced expression of CD94/NKG2A on CD8+ T lymphocytes from HCV-positive patients , 2003 .

[38]  Peter Parham,et al.  KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. , 2002, Annual review of immunology.

[39]  R. Biassoni,et al.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. , 2001, Annual review of immunology.

[40]  L. Moretta,et al.  HLA-class I-specific inhibitory receptors in HIV-1 infection. , 2000, Human immunology.

[41]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.